RGEN - CIK 0000730272
The table below shows REPLIGEN CORP's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $582.65M | $748.75M | $708.86M | $697.23M | $783.96M | $809.15M |
| Short-term investments | $201.88M | - | - | - | - | - |
| Receivables | $151.55M | $148.97M | $156.95M | $147.41M | $129.03M | $123.25M |
| Inventory | $179.26M | $160.32M | $155.86M | $153.11M | $182.47M | $190.53M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.16B |
| $1.10B |
| $1.06B |
| $1.03B |
| $1.13B |
| $1.16B |
| Property, plant & equipment | $173.46M | $188.93M | $193.49M | $195.52M | $202.58M | $204.60M |
| Goodwill | $1.11B | $1.11B | $1.11B | $1.08B | $987.62M | $985.61M |
| Total assets | $2.93B | $2.92B | $2.90B | $2.85B | $2.83B | $2.87B |
| Accounts payable | $34.66M | $29.43M | $25.63M | $26.93M | $21.36M | $20.91M |
| Total current liabilities | $126.21M | $131.14M | $123.01M | $152.00M | $108.37M | $174.81M |
| Long-term debt | $546.59M | $537.93M | - | - | - | - |
| Total liabilities | $825.31M | $840.62M | $839.89M | $866.66M | $813.96M | $881.57M |
| Retained earnings | $464.58M | $442.96M | $428.05M | $413.18M | $441.22M | $441.88M |
| Total equity | $2.11B | $2.08B | $2.06B | $1.99B | $2.02B | $1.98B |